GB948542A - Improvements in or relating to pharmaceutical compositions - Google Patents
Improvements in or relating to pharmaceutical compositionsInfo
- Publication number
- GB948542A GB948542A GB4631661A GB4631661A GB948542A GB 948542 A GB948542 A GB 948542A GB 4631661 A GB4631661 A GB 4631661A GB 4631661 A GB4631661 A GB 4631661A GB 948542 A GB948542 A GB 948542A
- Authority
- GB
- United Kingdom
- Prior art keywords
- syrup
- compositions
- indole alkaloids
- salts
- antitussive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Abstract
Antitussive compositions comprise one or more of the indole alkaloids alstonine, reserpinine, serpentine, isoreserpenine, serpentinine, tetrahydroserpentine, semperverine, d -yohimbine, and isoraunicine or non-toxic salts thereof together with a topical or local agent serving to soothe or pacify the mucous membrane in contact therewith e.g. sugar, simple syrup, cherry, orange, lemon and lime extracts, glycerine, sorbitol, propylene glycol, white pine syrup, fruit syrup. Emetics and expectorants e.g. ammonium chloride, potassium guaicolsulphonate, ipecacuanha, tartar emetic, squills, ammonium carbonate and alkali metal iodides and other active materials e.g. citric or ascorbic acid may also be present. The invention further comprises antitussive compositions in unit dosage form comprising a carrying vehicle and from 0.01 to 0.1 mg per unit dose of one or more of the above indole alkaloids or salts thereof. The compositions may be in conventional forms for oral or parenteral administration.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4631661A GB948542A (en) | 1961-12-27 | 1961-12-27 | Improvements in or relating to pharmaceutical compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4631661A GB948542A (en) | 1961-12-27 | 1961-12-27 | Improvements in or relating to pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB948542A true GB948542A (en) | 1964-02-05 |
Family
ID=10440747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4631661A Expired GB948542A (en) | 1961-12-27 | 1961-12-27 | Improvements in or relating to pharmaceutical compositions |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB948542A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2184352B (en) * | 1986-01-02 | 1990-05-09 | Warner Lambert Co | Compositions containing fructose. |
-
1961
- 1961-12-27 GB GB4631661A patent/GB948542A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2184352B (en) * | 1986-01-02 | 1990-05-09 | Warner Lambert Co | Compositions containing fructose. |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8402550L (en) | N-SUBSTITUTED DERIDATIVES OF MORANOLINE | |
| IL96995A0 (en) | Pharmaceutical compositions containing pimobendan and their preparation | |
| ES2032681T3 (en) | AN ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION, WITH ELIMINATION, IN SOLUTION, OF BITTER TASTE, BURNING OF THE THROAT AND INTESTINAL TOXICITY. (RESERVATION OF ART. 167.2 CPE). | |
| PE77999A1 (en) | METHOD FOR ADMINISTERING A HALOTHERAPY | |
| IT1217445B (en) | SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCISTEIN | |
| IE42950L (en) | X-ray contrast preparations | |
| GB1106157A (en) | Antacid tablets | |
| CA2050970A1 (en) | Pharmaceutical compositions containing furan derivatives | |
| ES370058A1 (en) | Antibiotic compositions | |
| GB948542A (en) | Improvements in or relating to pharmaceutical compositions | |
| IE791995L (en) | Formulation | |
| SE8204288L (en) | ANALGETIC COMPOSITION CONTAINING N-ACETYL-P-AMINOPHENOL IN COMBINATION WITH AN ANTACIDUM | |
| GB1202148A (en) | Pharmaceutical compositions | |
| GB1112567A (en) | Novel aqueous solutions and a process for the manufacture thereof | |
| SE8501312D0 (en) | ETOPOSIDE ORAL DOSAGE FORM | |
| GB1475861A (en) | Pharmaceutical composition | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| GB950162A (en) | Medicines for the treatment of hepatic disorders | |
| GB904955A (en) | Pharmaceutical compositions containing phloroglucinol | |
| IL31294A (en) | (hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them | |
| ATE270095T1 (en) | MEDICINAL PRODUCTS FOR USE IN THE MOUTH | |
| GB1091134A (en) | Pharmaceutical and veterinary compositions comprising a sorbitol acetal | |
| GB1110397A (en) | Ephedrine composition | |
| GB976096A (en) | Pharmaceutical compositions | |
| GB810537A (en) | Sweetening composition |